GlassScriptPhysician profile
Amer Kassar
NPI 1932208063
$143,488.42
in general payments reported to CMS, 2019-2025
73 companies · $5,802 in 2025
The $5,802 reported for 2025 was more than what 88% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $18K · 2021: $13K · 2022: $14K · 2023: $22K · 2024: $13K · 2025: $5,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,660 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,950 · Consulting Fee: $4,485 · Honoraria: $3,795 · Travel and Lodging: $1,587 · Gift: $119 · Education: $41.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,914.51 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,660.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,950.00 |
| Consulting Fee | $4,485.00 |
| Honoraria | $3,795.00 |
| Travel and Lodging | $1,587.27 |
| Gift | $118.80 |
| Education | $41.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $22,923.09 | 2019-2024 | |
| Dexcom, INC. | $16,049.54 | 2019-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14,880.80 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Merck Sharp & Dohme LLC | $11,798.23 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $9,267.08 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Janssen Pharmaceuticals, INC | $8,851.71 | 2019-2021 | |
| Lilly USA, LLC | $8,662.07 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $8,171.24 | 2019-2023 | Farxiga |
| Cequr Corporation | $5,943.98 | 2022-2024 | Cequr Simplicity |
| Bayer Healthcare Pharmaceuticals INC. | $5,858.15 | 2021-2025 | |
| Corcept Therapeutics | $5,305.34 | 2019-2025 | Korlym |
| Novo Nordisk INC | $3,014.93 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Recordati_rare_diseases_inc. | $2,380.24 | 2021-2025 | Isturisa, Signifor Lar |
| Abbott Laboratories | $2,230.78 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2, Eterna |
| Mannkind Corporation | $2,063.78 | 2019-2025 | Afrezza |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,503.64 | 2019-2025 | |
| Amgen INC. | $1,404.30 | 2019-2025 | Tepezza, Repatha, Repatha |
| Ascensia Diabetes Care US INC. | $1,306.19 | 2022-2025 | |
| Medtronic, INC. | $1,293.31 | 2021-2025 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Insulet Corporation | $1,138.18 | 2019-2023 | Omnipod |
| Zealand Pharma US, INC. | $1,025.51 | 2020-2022 | |
| Antares Pharma, INC. | $800.43 | 2019-2025 | Xyosted |
| Tandem Diabetes Care, INC. | $785.88 | 2020-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Esperion Therapeutics, INC. | $667.44 | 2020-2025 | Nexletol |
| Becton, Dickinson and Company | $497.93 | 2019-2022 | |
| Eusa Pharma (US) LLC | $495.33 | 2022 | |
| Amneal Pharmaceuticals LLC | $439.27 | 2021-2025 | Unithroid |
| Beta Bionics, INC. | $396.58 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ibsa Pharma INC. | $390.94 | 2019-2024 | Tirosint, Licart, Licart |
| Madrigal Pharmaceuticals | $373.48 | 2024-2025 | Rezdiffra, Resmetirom |
| Intuity Medical INC | $328.57 | 2022 | |
| Novartis Pharmaceuticals Corporation | $295.56 | 2022-2025 | |
| Sequel Med Tech, LLC | $266.51 | 2025 | Twiist |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $246.11 | 2021-2024 | Cycloset |
| Valeritas, INC. | $177.20 | 2019 | |
| Ascendis Pharma Endocrinology INC | $160.50 | 2023-2025 | Yorvipath |
| Halozyme INC | $145.04 | 2023 | |
| Amarin Pharma, INC. | $142.98 | 2020-2021 | |
| Clarus Therapeutics INC. | $130.01 | 2020-2021 | |
| Embecta Corp. | $128.15 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Shire North American Group INC | $105.72 | 2019 | |
| Optinose US, INC. | $100.60 | 2022 | |
| Currax Pharmaceuticals LLC | $98.83 | 2020-2024 | Contrave |
| Amryt Pharma Holdings LTD | $96.64 | 2022 | |
| Medtronic Minimed, INC. | $87.81 | 2019-2020 | |
| Astellas Pharma US INC | $78.10 | 2023-2025 | Veozah |
| Horizon Therapeutics Plc | $67.01 | 2020-2023 | Tepezza |
| Allergan, INC. | $64.31 | 2019 | |
| Acella Pharmaceuticals, LLC | $61.32 | 2024-2025 | NP Thyroid 60 |
| Avvisto Therapeutics, LLC | $60.16 | 2024-2025 | Cycloset |
| Takeda Pharmaceuticals U.S.A., INC. | $59.50 | 2020 | |
| Alnylam Pharmaceuticals INC. | $55.18 | 2020 | |
| Lifescan, INC. | $53.52 | 2019-2021 | |
| Radius Health, INC. | $50.99 | 2024-2025 | Tymlos |
| Ironwood Pharmaceuticals, INC | $48.74 | 2021-2023 | Linzess |
| Itamar Medical INC | $43.23 | 2022-2023 | Watchpatone |
| Almatica Pharma LLC | $43.20 | 2025 | Loreev Xr, Teriparatide |
| Merz Pharmaceuticals, LLC | $42.52 | 2024 | Xeomin |
| Companion Medical, INC. | $41.51 | 2019 | |
| Neurocrine Biosciences, INC. | $40.26 | 2024-2025 | |
| Pfizer INC. | $37.58 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $29.60 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $25.95 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $21.25 | 2025 | Imcivree |
| Chiesi USA, INC. | $20.38 | 2024 | Myalept |
| Roche Diabetes Care, INC. | $19.10 | 2021 | |
| Eisai INC. | $16.89 | 2019 | |
| Azurity Pharmaceuticals, INC. | $15.72 | 2023 | Adthyza |
| Galderma Laboratories, L.P. | $15.39 | 2023 | |
| Amphastar Pharmaceuticals, INC. | $14.75 | 2025 | |
| Glaxosmithkline, LLC. | $13.82 | 2025 | Arexvy |
| Gilead Sciences, INC. | $13.07 | 2019 | |
| Theracosbio, LLC | $5.77 | 2024 | Brenzavvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amer Kassar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.